In vitro release characteristics of bioactive molecules from dextran dialdehyde cross-linked gelatin hydrogel films

Biomaterials

Volumn 19, Issue 1-3, 1998, Pages 99-107

  Draye, Jean Pierre ^a   Delaey, Bernard ^a   Van De Voorde, André ^a   Van Den Bulcke, An ^b   Bogdanov, Bogdan ^b   Schacht, Etienne ^b  

^a INNOGENETICS   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Gelatin films; Growth factors; Hydrogels; Release

Indexed keywords

ALDEHYDES; CROSSLINKING; GELATION; GROWTH KINETICS; HYDROGELS; MECHANICAL PROPERTIES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYPEPTIDES; REACTION KINETICS; RHEOLOGY;

DEXTRAN DIALDEHYDES; EPIDERMAL GROWTH FACTOR (EGF); HYDROGEL FILMS;

BIOMATERIALS;

DEXTRAN DERIVATIVE; EPIDERMAL GROWTH FACTOR; GELATIN; POLYPEPTIDE;

ARTICLE; CROSS LINKING; HYDROGEL; KINETICS; MECHANICS; PRIORITY JOURNAL; STORAGE; SUSTAINED RELEASE PREPARATION; TIME; WOUND HEALING;

ANIMALS; CELLS, CULTURED; CHEMISTRY, PHYSICAL; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DEXTRANS; ELASTICITY; EPIDERMAL GROWTH FACTOR; FLUORESCEIN-5-ISOTHIOCYANATE; GELATIN; HYDROGEL; IODINE RADIOISOTOPES; KINETICS; MICE; MICE, INBRED BALB C; POLYETHYLENE GLYCOLS; PROTEINS; SERUM ALBUMIN, BOVINE; VISCOSITY;

EID: 0031842013     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(97)00164-6     Document Type: Article

References (45)

1. [1] Neumann PM, Zur B, Ehrenreich Y. Gelatin-based sprayable foam as skin substitute. J Biomed Mater Res 1981;15:9-18.
2. [2] Petersen JK, Krogsgaard J, Nielsen KM, Nørgaard EB. A comparison between 2 absorbable hemostatic agents: gelatin sponge (Spongostan) and oxidized regenerated cellulose (Surgical). Int J Oral Surg 1984;13:406-410.
3. [3] Takahashi H, Miyoshi T, Boki K. Study on hydrophilic properties of gelatin as clinical wound dressing. II. Water-absorbing property and hemostatic effect of gelatin. Tokushima J Exp Med 1993;40:169-75.
4. [4] Reuterving C-O, Ågren MS, Söderberg TA, Tengrup I, Hallmans, G. The effects of occlusive dressings on inflammation and granulation tissue formation in excised wounds in rats. Scand J Plast Reconstr Surg Hand Surg 1989;23:89-96.
5. [5] Tabata Y, Ikada Y. Synthesis of gelatin microspheres containing interferon. Pharm Res 1989;6:422-27.
6. [6] Yan C, Li X, Chen X, Wang D, Zhong D, Tan T, Kitano H. Anticancer gelatin microspheres with multiple functions. Biomaterials 1991;12:640-44.
7. [7] Shinde BG, Erhan S. Flexibilized gelatin film-based artificial skin model. II. Release kinetics of incorporated bioactive molecules. BioMed Mater Eng 1992;2:127-31.
8. [8] Di Silvio L, Gurav N, Kayser MV, Braden M, Downes S. Biodegradable microspheres: a new delivery system for growth hormone. Biomaterials 1994;15:931-36.
9. [9] Altankov G, Brodvarova I, Rashkov I. Synthesis of protein-coated gelatin microspheres and their use as microcarriers for cell culture. Part I. Derivatization with native collagen. J Biomater Sci Polym Ed 1991;2:81-89.
10. [10] Lou Y, Groves MJ. The use of gelatin microparticles to delay the release of readily water-soluble materials. J Pharm Pharmacol 1995;47:97-102.
11. [11] Schacht EH, Nobels M, Vansteenkiste S, Demeester J, Fransen J, Lemahieu A. Cross-linkage of gelatin by dextran dialdehydes. Polym. Gels Networks 1993;1:213-24.
12. [12] Levy MC, Andry M-C. Mixed-walled microcapsules made of cross-linked proteins and polysaccharides: preparation and properties. J Microencapsul 1991;8:335-47.
13. [13] Yamamoto N, Kurisawa M, Yui N. Double-stimuli-responsive degradable hydrogels: interpenetrating polymer networks consisting of gelatin and dextran with different phase separation. Macromol Rapid Commun 1996;17:313-18.
14. [14] Brannon-Peppas L. Enzymatically degradable polymers based upon polysaccharides for controlled drug delivery. In: 23rd International Symposium on Controlled Release of Bioactive Materials, Kyoto, Japan, Abstract book, 7-10 July 1996:21-22.
15. [15] Pierce GF, Mustoe TA. Pharmacological enhancement of wound healing. Annu Rev Med 1995;46:467-81.
16. [16] Hunt T. Wound fluid: the growth environment. In: Barbul A, Caldwell MD, Eaglstein WH et al., editors. Clinical and experimental approaches to dermal and epidermal repair: normal and chronic wounds. New York: Wiley-Liss, 1991:223-30.
17. [17] Cooper DM, Yu YZ, Hennessey P et al. Determination of endogenous cytokines in chronic wounds. Ann Surg 1994;219:688-692.
18. [18] Broadley KN, Aqquino AM, Woodward SC et al. Specific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest 1989;61:571-75.
19. [19] Lynch SE, Nixon JC, Colvin RB, Antoniades HN. Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci USA 1987; 84:7696-700.
20. [20] Hebda PA, Klingbeil CK, Abraham JA, Fiddes JC. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 1990;95:626-31.
21. [21] Nanney LB. Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol 1990;94:624-29.
22. [22] Hennessey PJ, Black CT, Andrassy RJ. EGF increases short-term type I collagen accumulation during wound healing in diabetic rats. J Pediatric Surg 1990;25:893-97.
23. [23] Greenhalgh DG, Hummel III R, Albertson S, Breeden MP, Synergistic actions of platelet-derived growth factor and the insulin-like growth factors in vivo. Enhancement of tissue repair in genetically diabetic mice. Wound Rep Reg 1993;1:69-81.
24. [24] Ksander GA, Gerhardt CO, Olsen DR. Exogenous transforming growth factor-β2 enhances connective tissue formation in transforming growth factor-β1-deficient, healing-impaired dermal wounds in mice. Wound Rep Reg 1993;1:137-48.
25. [25] Tsuboi R, Shi C-M, Sato C, Cox GN, Ogawa H, Co-administration of insulin-like growth factor (IGF)I and IGF-binding protein-1 stimulates wound healing in animals models. J Invest Dermatol 1995;104:199-203.
26. [26] Duinslager L, Verbeken G, Reper P, Delaey B, Van Halle S, Vanderkelen A. Lyophilized keratinocyte cell lysates contain multiple mitogenic activities and stimulate closure of meshed skin autograft-covered burn wounds with similar efficiancy as fresh allogenic keratinocyte cultures. J Plast Reconstr Surg 1996;98:110-17.
27. [27] Somers T, Verbeken G, Vanhalle S et al. Lysates from cultured allogenic keratinocytes stimulate wound healing after tympanoplasty. Acta Otolaryngol (Stockh) 1996;116:589-93.
28. [28] Brown GL, Curtsinger L, Jurkiewicz MJ, Nahai F, Schultz G. Stimulation of healing of chronic wounds by epidermal growth factor. Plast Reconstr Surg 1991;88:189-94.
29. [29] Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet 1992;339:23-25.
30. [30] Robson MC, Phillip LG, Cooper DM et al. Safety and effect of transforming growth factor-β2 for treatment of venous stasis ulcers. Wound Rep Reg 1995;3:157-67.
31. [31] Matsuda K, Suzuki S, Isshiki N et al. Safety and effect of transforming growth factor-β2 for treatment of venous stasis ulcers. Wound Rep Reg 1995;3:157-67.
32. [32] Heya T, Mikura Y, Nagai A et al. Contolled release of thyrotropin releasing hormone from microspheres: evaluation of release profiles and pharmacokinetics after subcutaneous administration. J Pharm Sci 1994;6:798-801.
33. [33] Ron E, Turck T, Mathiowitz E, Chasin M, Hageman M. Langer R. Controlled release of polypeptides from polyanhydrides. Proc Natl Acad Sci USA 1993;90:4176-80.
34. [34] Johnson O, Cleland JL, Lee HJ et al. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med 1996;2:795-99.
35. [35] Bersch PC, Nies B, Liebendörfer A, Kreuter J. Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics. Biomaterials 1994;15:593-600.
36. [36] Ko C, Dixit V, Shaw W, Gitmick G. In vivo slow release profile of endothelial cell growth factor immobilized within calcium alginate microbeads. Artif Cells Blood Substit Immobil Biotechnol 1995;23:143-51.
37. [37] Golumbek PT, Azhari R, Jaffee EM et al. Controlled release biodegradable cytokine depots: a new approach in cancer vaccine design. Cancer Res 1993;53:5841-44.
38. [38] Cortesi R, Esosito E, Menegatti E, Gambri R, Nastruzzi C. Gelatin microspheres as a new approach for controlled delivery of synthetic oligonucleotides and PCR-generated DNA fragments. Int J Pharm 1994;105:181-86.
39. [39] Tabata Y, Ikada Y. Synthesis of gelatin microspheres containing interferon. Pharm Res 1989;6:422-27.
40. [40] Roth M. Fluorescence reaction for amino acids. Anal Chem 1971;43:880-82.
41. [41] Ruys L, Vermeersch J, Schacht E et al. Polymer drug combinations. VII. Polymethacrylates and modified polysaccharides with potential antiarrhythmic activity. Acta Pharm Technol 1983; 29:105-12.
42. [42] Schacht EH, Bogdanov B, Van Den Bulcke A, De Rooze N. Hydrogels for immobilization of bioactive agents. In: 7th International Conference on Polymer Supported Reactions in Organic Chemistry, Wroclaw, Poland, Abstract book, 24-28 June 1996:78-79.
43. [43] Falco JF, Taylor WG, Di Fiore PP, Weissman BE, Aaronson AA. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes. Oncogene 1988;2:573-78.
44. [44] Schacht EH, Bogdanov B, Van Den Bulcke A, De Rooze N. Hydrogels prepared by crosslinkage of gelatin with dextran dialdehyde. Reactive Funct Polym 1997;33:109-16.
45. [45] Rao JK, Ramesh V, Rao KP. Controlled release systems for proteins based on gelatin micospheres. J Biomater Sci Polym Ed 1994;6:391-98.